Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
96.5M
-
Number of holders
-
7
-
Total 13F shares, excl. options
-
1.62M
-
Shares change
-
+1.62M
-
Total reported value, excl. options
-
$27.4M
-
Value change
-
+$27.4M
-
Number of buys
-
7
-
Price
-
$16.89
Significant Holders of AVADEL PHARMACEUTICALS PLC - Common Stock (AVDL) as of Q1 2024
7 filings reported holding AVDL - AVADEL PHARMACEUTICALS PLC - Common Stock as of Q1 2024.
AVADEL PHARMACEUTICALS PLC - Common Stock (AVDL) has 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.62M shares
of 96.5M outstanding shares and own 1.68% of the company stock.
Largest 7 shareholders include Cutter Capital Management, LP (542K shares), Driehaus Capital Management LLC (475K shares), MARSHALL WACE, LLP (384K shares), STEMPOINT CAPITAL LP (224K shares), Lindbrook Capital, LLC (98 shares), Parallel Advisors, LLC (42 shares), and Avior Wealth Management, LLC (42 shares).
This table shows the top 7 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.